At a glance
- Originator Pharmacia Corporation
- Class Antidepressants; Propylamines; Small molecules
- Mechanism of Action Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 14 Feb 1997 Discontinued-Preclinical for Depression in Italy (Unknown route)
- 31 Dec 1996 No-Development-Reported for Depression in Italy (Unknown route)